There were 1,566 press releases posted in the last 24 hours and 430,716 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Matinas BioPharma's Lead Antifungal Product Candidate MAT2203 Granted QIDP and Fast Track Designations for Prophylaxis of Invasive Fungal Infections by U.S. FDA

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image